[pdf] patents office journal - Irish Patents Office

813
(05/04/2006) Patents Office Journal (No. 2043)
containing these compounds, their use and processes for their production
Product: Primovist
Market Authorisation: Ireland PA 12/98/1; PA 12/98/2, 19/11/2004
Sweden 18929; 18930, 26/03/2004
Certificate Expires on: 25/06/2015
Supplementary Protection Certificates Rejected
The name and address of the requestor follow the number allocated to the request. The date in brackets,
following the name and address, is the date of receipt of the request. The patent number is that under which
the product in respect of which a certificate is sought is, allegedly, protected. Market authorisation references
in respect of the product concerned are also shown.
1999/002 NOVARTIS AG
Schwarzwaldallee 215, 4058 Basel, Switzerland
(26 February 1999)
Patent No. 71155 Acyl Compounds
Product: Valsartan or a pharmaceutically acceptable salt or ester thereof in combination
with hydrochlorothiazide
Market Authorisation: Ireland PA 13/91/1 (10 December 1998)
France 344 300-5, 344 301-1, 344 302-1, 344 303-4 (25
September 1997)
Application rejected under Article 10(2) of Council Regulation (EEC) No. 1768/92
2000/014 GALDERMA RESEARCH & DEVELOPMENT
Sophia Antipolis, 06560 Valbonne, France
(17 July 2000)
Patent No. 58882 Benzonaphthalene derivatives, a process for their preparation and
their use in therapeutic and cosmetic compositions
Product: Adapalene, including pharmaceutically acceptable salts or esters thereof
Market Authorisation: Ireland PA 590/6/3 (18 February 2000)
France NL 19410 (25 March 1997)
NL 22048 (09 July 1997)
Application rejected under Article 10(4) of Council Regulation (EEC) No. 1768/92